Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

White House threatens to veto Republicans' Zika funding plan

Published 06/23/2016, 06:32 PM
© Reuters. Obama talks to reporters after a briefing on the administration's response to the Zika virus in the Oval Office at the White House in Washington

By Roberta Rampton and Susan Cornwell

WASHINGTON (Reuters) - The White House on Thursday threatened to veto the $1.1 billion approved by the U.S. House of Representatives to fight the Zika virus, blasting the measure for short-changing the administration's $1.9 billion funding request.

The Republican-controlled House approved the funding deal early Thursday morning after reaching a deal with both House and Senate Republicans.

White House spokesman Eric Schultz said the bill "falls far short" of the amount of money recommended by health officials to address the spread of the Zika virus.

"This is a bill that would steal money from other critically important public health priorities," Schultz told reporters at a briefing. "We urge Republicans to stop turning this into a political football, and to actually get to work to come up with proposals that will serve the American people."

The administration also criticized the bill for limiting contraception access for women seeking to prevent Zika, which can be spread through unprotected sex.

The Senate is expected to vote on funding to combat the Zika virus next week, but the bill faces an uncertain fate in the chamber, where the Democratic minority has more power to stop legislation. Democratic leader Harry Reid has declared his opposition.

Republican House Speaker Paul Ryan urged the Senate to move on the bill.

"It is a responsible plan that assures the administration will continue to have the needed resources to protect the public," Ryan said. Republicans said the deal included funding for fiscal years 2016 and 2017.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

If the Senate approved the bill, a White House veto would likely mean that lawmakers would not take up the issue until the House and Senate return from their July 4 holiday recess - well into the U.S. summer season. The House has already adjourned for holiday and the Senate is expected to start its recess next Friday.

Democrats have been urging Republicans for months to agree to more Zika funding, and the Obama administration has already reprogrammed nearly $600 million that had been set aside to fight Ebola.

House Democrats said they could not go along with the deal because of $750 million in budget cuts elsewhere that the Republicans want to use to pay for the Zika spending.

Senate Democrats also voiced displeasure, clouding the outlook for it passing.

"A narrowly partisan proposal that cuts off women's access to birth control, shortchanges veterans and rescinds Obamacare funds to cover the cost is not a serious response to the threat from the Zika virus," Reid said.

According to House Appropriations Committee Chairman Hal Rogers, $543 million of the $1.1 billion would come from unspent funds set aside for implementing Obamacare in U.S. territories, while $107 million would come from unused funds to fight another virus, Ebola. Another $100 million would come from unused administrative funds at the Department of Health and Human Services, he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.